PICO Portalanswers from OpenAlex
Teclistamab in Relapsed or Refractory Multiple Myeloma
PaperCitations, authors & open-access status
Teclistamab in Relapsed or Refractory Multiple Myeloma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Teclistamab in Relapsed or Refractory Multiple Myeloma have?
PICO Portalcitation count
Teclistamab in Relapsed or Refractory Multiple Myeloma has 1,160 citations in the OpenAlex counts PICO Portal stores.
When was Teclistamab in Relapsed or Refractory Multiple Myeloma published?
PICO Portalyear
Teclistamab in Relapsed or Refractory Multiple Myeloma has 2022 year in the PICO Portal index.
What is the open-access status of Teclistamab in Relapsed or Refractory Multiple Myeloma?
PICO Portaloa status
Teclistamab in Relapsed or Refractory Multiple Myeloma has bronze oa status in the PICO Portal index.
What is the DOI of Teclistamab in Relapsed or Refractory Multiple Myeloma?
PICO Portaldoi
The DOI for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.
What is the PMID of Teclistamab in Relapsed or Refractory Multiple Myeloma?
PICO Portalpmid
The PMID for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.
What is the OpenAlex record for Teclistamab in Relapsed or Refractory Multiple Myeloma?
PICO Portalopenalex
The OpenAlex for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.